For example, EMP1 promotes tumor metastasis by enhancing cell migration in prostate cancer [26], whereas EMP2 acts as an oncogenic protein in endometrial cancer cells, with high EMP2 related to increased lymphovascular invasion and poor survival [27,28,29]. Here, EMP1 is linked to Familial prostate cancer.